Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jan-Dec:10:23247096221140248.
doi: 10.1177/23247096221140248.

Idiopathic Intracranial Hypertension: An Unusual Cause of Headache in a Patient With Sickle Cell Disease

Affiliations
Case Reports

Idiopathic Intracranial Hypertension: An Unusual Cause of Headache in a Patient With Sickle Cell Disease

Toby Terwilliger et al. J Investig Med High Impact Case Rep. 2022 Jan-Dec.

Abstract

Idiopathic intracranial hypertension (IIH) is a rare cause of headache and visual disturbance with no known association with sickle cell disease (SCD). We present a patient with SCD with gradual onset of a severe headache and visual changes. Brain magnetic resonance imaging, angiography, and venography were nondiagnostic. Lumbar puncture established a diagnosis of IIH, and the patient had rapid improvement with large-volume lumbar puncture and acetazolamide. To our knowledge, this is the first case of IIH in a nonobese adult with SCD taking hydroxyurea, suggesting an association between SCD or hydroxyurea use and IIH. Furthermore, her clinical course demonstrates the complexities of treating IIH in patients with SCD.

Keywords: case report; headache; idiopathic intracranial hypertension; sickle cell disease.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Similar articles

References

    1. Niebanck AE, Pollock AN, Smith-Whitley K, et al.. Headache in children with sickle cell disease: prevalence and associated factors. J Pediatr. 2007;151(1):67-72.e1. doi:10.1016/j.jpeds.2007.02.015 - DOI - PMC - PubMed
    1. Vgontzas A, Charleston L, Robbins MS. Headache and facial pain in sickle cell disease. Curr Pain Headache Rep. 2016;20(3):20. doi:10.1007/s11916-016-0546-z - DOI - PubMed
    1. Markey KA, Mollan SP, Jensen RH, Sinclair AJ. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016;15(1):78-91. doi:10.1016/S1474-4422(15)00298-7 - DOI - PubMed
    1. Chen J, Wall M. Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin. 2014;54(1):1-11. doi:10.1097/IIO.0b013e3182aabf11 - DOI - PMC - PubMed
    1. Millichap JG. Pseudotumor cerebri and sickle cell disease. Pediatr Neurol Briefs. 2004;18(3):17-18. doi:10.15844/pedneurbriefs-18-3-1 - DOI

Publication types